Lung-RADS v2022 Screening — Structured Report

Low-dose CT lung cancer screening — Lung-RADS v2022 categorization.

CTChestv1Lung-RADS® v2022 →

Report inputs

Low-dose CT lung cancer screening — Lung-RADS v2022 categorization.

Exam & background

Exam type

Prior study available

Emphysema

Fibrosis

Prior malignancy

Nodules

No Nodule yet.

Lymph nodes

Enlarged mediastinal node

Enlarged hilar node

Largest short axis (mm)(mm)

Nodal necrosis

Airways / pleura / other

Endobronchial lesion

Pleural effusion

Pleural thickening

Significant/potentially significant incidental finding (S)

Other findings

Summary

Nodules0

Lung-RADS: ___.

Staging / Classification

Nodules0

Full report

EXAM & BACKGROUND
- Exam type: LDCT screening
- Prior study available: —
- Emphysema: —
- Fibrosis: —
- Prior malignancy: —

NODULES
- Nodules: —

LYMPH NODES
- Enlarged mediastinal node: —
- Enlarged hilar node: —
- Largest short axis (mm): —
- Nodal necrosis: —

AIRWAYS / PLEURA / OTHER
- Endobronchial lesion: —
- Pleural effusion: —
- Pleural thickening: —
- Significant/potentially significant incidental finding (S): —
- Other findings: —

Nodules: 0

Based on Lung-RADS® v2022.

Evidence

Lung-RADS v2022 classifies screening LDCT findings into categories 0–4X with S modifier, driving management. — ACR Lung-RADS v2022